TP53 mutation was also observed in 24% (5 of 21) of cases with nasal NK/T-cell lymphoma from Mexico, associated with large cell morphology and advanced-stage disease [630]. The gene discussed is TP53; the disease is extranodal nasal NK/T cell lymphoma.